scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic

TL;DR: Survival to discharge was lower during the pandemic compared with 2019, and incidence of OHCA was higher than in 2019, but the increase was largely observed in communities with high COVID-19 mortality (adjusted mean difference, 38.6 [95% CI, 37.1-40.1] per million residents) and very high CO VID-19 deaths.
Abstract: Importance Recent reports from communities severely affected by the coronavirus disease 2019 (COVID-19) pandemic found lower rates of sustained return of spontaneous circulation (ROSC) for out-of-hospital cardiac arrest (OHCA). Whether the pandemic has affected OHCA outcomes more broadly is unknown. Objective To assess the association between the COVID-19 pandemic and OHCA outcomes, including in areas with low and moderate COVID-19 disease burden. Design, Setting, and Participants This study used a large US registry of OHCAs to compare outcomes during the pandemic period of March 16 through April 30, 2020, with those from March 16 through April 30, 2019. Cases were geocoded to US counties, and the COVID-19 mortality rate in each county was categorized as very low (0-25 per million residents), low (26-100 per million residents), moderate (101-250 per million residents), high (251-500 per million residents), or very high (>500 per million residents). As additional controls, the study compared OHCA outcomes during the prepandemic period (January through February) and peripandemic period (March 1 through 15). Exposure The COVID-19 pandemic. Main Outcomes and Measures Sustained ROSC (≥20 minutes), survival to discharge, and OHCA incidence. Results A total of 19 303 OHCAs occurred from March 16 through April 30 in both years, with 9863 cases in 2020 (mean [SD] age, 62.6 [19.3] years; 6040 men [61.3%]) and 9440 in 2019 (mean [SD] age, 62.2 [19.2] years; 5922 men [62.7%]). During the pandemic, rates of sustained ROSC were lower than in 2019 (23.0% vs 29.8%; adjusted rate ratio, 0.82 [95% CI, 0.78-0.87];P Conclusions and Relevance Early during the pandemic, rates of sustained ROSC for OHCA were lower throughout the US, even in communities with low COVID-19 mortality rates. Overall survival was lower, primarily in communities with moderate or high COVID-19 mortality.

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI
TL;DR: The 2023 Statistical Update as mentioned in this paper provides the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health.
Abstract: Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). Methods: The American Heart Association, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2023 Statistical Update is the product of a full year’s worth of effort in 2022 by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. The American Heart Association strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional COVID-19 (coronavirus disease 2019) publications, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains. Results: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. Conclusions: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

300 citations

Journal ArticleDOI
TL;DR: The 2023 Statistical Update as mentioned in this paper provides the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health.
Abstract: Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). Methods: The American Heart Association, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2023 Statistical Update is the product of a full year’s worth of effort in 2022 by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. The American Heart Association strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional COVID-19 (coronavirus disease 2019) publications, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains. Results: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. Conclusions: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

114 citations

Journal ArticleDOI
Gavin D. Perkins1, Jan-Thorsen Gräsner, Federico Semeraro, Theresa M. Olasveengen2, Jasmeet Soar3, Carsten Lott4, Patrick Van de Voorde5, John Madar, David Zideman, Spyridon Mentzelopoulos6, Leo Bossaert7, Robert Greif8, Robert Greif9, Koen Monsieurs7, Hildigunnur Svavarsdóttir10, Jerry P. Nolan11, Jerry P. Nolan1, Sean Ainsworth, S. Akin, A. Alfonzo, Janusz Andres, S. Attard Montalto, A. Barelli, M. Baubin, W. Behringer, B. Bein, Dominique Biarent, Robert Bingham, M. Blom, A. Boccuzzi, V. Borra, L. Bossaert7, Bernd W. Böttiger, Jan Breckwoldt, O. Brissaud, R. Burkart, A. Cariou, Pierre Carli, Francesc Carmona, P. Cassan, Maaret Castren, T. Christophides, C. D. Cimpoesu, C. Clarens, Patricia Conaghan, Keith Couper, Tobias Cronberg, E. De Buck, N. De Lucas, A. de Roovere, Charles D. Deakin, J. Delchef, B. Dirks, Jana Djakow, Therese Djärv, P. Druwe, G. Eldin, Hege Langli Ersdal, H. Friberg, C. Genbrugge, Marios Georgiou, E. Goemans, Violeta González-Salvado, P. Gradisek, J.T. Graesner, R. Greif8, Anthony J. Handley, C. Hassager, Kirstie L. Haywood, J. K. Heltne, D. Hendrickx, Johan Herlitz, Jochen Hinkelbein, Florian Hoffmann, S. Hunyadi Anticevic, Groa Bjork Johannesdottir, Gamal Eldin Abbas Khalifa, B. Klaassen, J. Koppl, U. Kreimeier, Artem Kuzovlev, Torsten Lauritsen, Gisela Lilja, Freddy Lippert, Andy Lockey, C. Lott4, I. Lulic, M. Maas, Ian Maconochie, J. Madar, Abel Martinez-Mejias, Siobhán Masterson, Spyros D. Mentzelopoulos6, D. Meyran, Koenraad G. Monsieurs7, Colin J Morley, V. R. M. Moulaert, N. Mpotos, Nikolaos I. Nikolaou, J. P. Nolan1, T. M. Olasveengen2, E. Oliver, Peter Paal, Tommaso Pellis, G. D. Perkins1, Lucas Pflanzl-Knizacek, K. Pitches, Kurtis Poole, Violetta Raffay, W. Renier, Giuseppe Ristagno, Charles Christoph Roehr, Fernando Rosell-Ortiz, Mario Rüdiger, A. Safri, L. Sanchez Santos, Claudio Sandroni, Ferenc Sari, Andrea Scapigliati, S. Schilder, J. Schlieber, Sebastian Schnaubelt, Federico Semeraro, Salma Shammet, E. M. Singletary, Christiane Skåre, Markus B. Skrifvars, Michael Smyth, J. Soar3, H. Svavarsdottir10, Tomasz Szczapa, F. Taccone, M. Tageldin Mustafa, A.B. te Pas, Karl-Christian Thies, Ingvild Tjelmeland, Daniele Trevisanuto, A. Truhlar, G. Trummer, N. M. Turner, Berndt Urlesberger, J. Vaahersalo, P. Van de Voorde, H. van Grootven, Dominic Wilkinson, Jan Wnent, Jonathan Wyllie, Joyce Yeung, D. A. Zideman 
TL;DR: The European Resuscitation Council Guidelines as mentioned in this paper present the most up-to-date evidence-based guidelines for the practice of resuscitation across Europe, which cover the epidemiology of cardiac arrest; the role that systems play in saving lives, adult basic life support, adult advanced life support.

44 citations

Journal ArticleDOI
TL;DR: In this article , the authors evaluate the association between the volume of cardiac arrest and acute coronary syndrome EMS calls in the 16-39-year-old population with potential factors including COVID-19 infection and vaccination rates.
Abstract: Abstract Cardiovascular adverse conditions are caused by coronavirus disease 2019 (COVID-19) infections and reported as side-effects of the COVID-19 vaccines. Enriching current vaccine safety surveillance systems with additional data sources may improve the understanding of COVID-19 vaccine safety. Using a unique dataset from Israel National Emergency Medical Services (EMS) from 2019 to 2021, the study aims to evaluate the association between the volume of cardiac arrest and acute coronary syndrome EMS calls in the 16–39-year-old population with potential factors including COVID-19 infection and vaccination rates. An increase of over 25% was detected in both call types during January–May 2021, compared with the years 2019–2020. Using Negative Binomial regression models, the weekly emergency call counts were significantly associated with the rates of 1st and 2nd vaccine doses administered to this age group but were not with COVID-19 infection rates. While not establishing causal relationships, the findings raise concerns regarding vaccine-induced undetected severe cardiovascular side-effects and underscore the already established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young individuals. Surveillance of potential vaccine side-effects and COVID-19 outcomes should incorporate EMS and other health data to identify public health trends (e.g., increased in EMS calls), and promptly investigate potential underlying causes.

21 citations

Journal ArticleDOI
TL;DR: In this article, the authors reviewed the effects of the COVID-19 pandemic on out-of-hospital cardiac arrest (OHCA) epidemiology and systems of care, and found that areas severely affected by the pandemic have reported increased incidence of OHCA, lower rates of successful resuscitation, and increased mortality.
Abstract: PURPOSE OF REVIEW: The emergence of severe acute respiratory syndrome coronavirus 2 virus, which causes coronavirus disease 2019 (COVID-19), led to the declaration of a global pandemic by the World Health Organization on March 11, 2020. As of February 6, 2021, over 105 million persons have been infected in 223 countries and there have been 2,290,488 deaths. As a result, emergency medical services and hospital systems have undergone unprecedented healthcare delivery reconfigurations. Here, we review the effects of the COVID-19 pandemic on out-of-hospital cardiac arrest (OHCA) epidemiology and systems of care. RECENT FINDINGS: Areas severely affected by the pandemic have reported increased incidence of OHCA, lower rates of successful resuscitation, and increased mortality. COVID-19 has significantly impacted patient outcomes through increased disease severity, decreased access to care, and the reshaping of emergency medical response and hospital-based healthcare systems and policies. The pandemic has negatively influenced attitudes toward resuscitation and challenged providers with novel ethical dilemmas provoked by the scarcity of healthcare resources. SUMMARY: The COVID-19 pandemic has had direct, indirect, psychosocial, and ethical impacts on the cardiac arrest chain of survival.

19 citations

References
More filters
Journal ArticleDOI
TL;DR: Results from a limited simulation study indicate that this approach is very reliable even with total sample sizes as small as 100, and the method is illustrated with two data sets.
Abstract: Relative risk is usually the parameter of interest in epidemiologic and medical studies. In this paper, the author proposes a modified Poisson regression approach (i.e., Poisson regression with a robust error variance) to estimate this effect measure directly. A simple 2-by-2 table is used to justify the validity of this approach. Results from a limited simulation study indicate that this approach is very reliable even with total sample sizes as small as 100. The method is illustrated with two data sets.

7,045 citations

Journal ArticleDOI
TL;DR: A task force of the International Liaison Committee on Resuscitation (ILCOR) met in Melbourne, Australia, to review worldwide experience with the Utstein definitions and reporting templates as mentioned in this paper.
Abstract: Outcome after cardiac arrest and cardiopulmonary resuscitation is dependent on critical interventions, particularly early defibrillation, effective chest compressions, and advanced life support. Utstein-style definitions and reporting templates have been used extensively in published studies of cardiac arrest, which has led to greater understanding of the elements of resuscitation practice and progress toward international consensus on science and resuscitation guidelines. Despite the development of Utstein templates to standardize research reports of cardiac arrest, international registries have yet to be developed. In April 2002, a task force of the International Liaison Committee on Resuscitation (ILCOR) met in Melbourne, Australia, to review worldwide experience with the Utstein definitions and reporting templates. The task force revised the core reporting template and definitions by consensus. Care was taken to build on previous definitions, changing data elements and operational definitions only on the basis of published data and experience derived from those registries that have used Utstein-style reporting. Attention was focused on decreasing the complexity of the existing templates and addressing logistical difficulties in collecting specific core and supplementary (ie, essential and desirable) data elements recommended by previous Utstein consensus conferences. Inconsistencies in terminology between in-hospital and out-of-hospital Utstein templates were also addressed. The task force produced a reporting tool for essential data that can be used for both quality improvement (registries) and research reports and that should be applicable to both adults and children. The revised and simplified template includes practical and succinct operational definitions. It is anticipated that the revised template will enable better and more accurate completion of all reports of cardiac arrest and resuscitation attempts. Problems with data definition, collection, linkage, confidentiality, management, and registry implementation are acknowledged and potential solutions offered. Uniform collection and tracking of registry data should enable better continuous quality improvement within every hospital, emergency medical services system, and community.

2,277 citations

Journal ArticleDOI
Peter C. Austin1
TL;DR: The utility and interpretation of the standardized difference for comparing the prevalence of dichotomous variables between two groups is explored, and a standardized difference of 10% is equivalent to having a phi coefficient of 0.05 for the correlation between treatment group and the binary variable.
Abstract: Researchers are increasingly using the standardized difference to compare the distribution of baseline covariates between treatment groups in observational studies. Standardized differences were initially developed in the context of comparing the mean of continuous variables between two groups. However, in medical research, many baseline covariates are dichotomous. In this article, we explore the utility and interpretation of the standardized difference for comparing the prevalence of dichotomous variables between two groups. We examined the relationship between the standardized difference, and the maximal difference in the prevalence of the binary variable between two groups, the relative risk relating the prevalence of the binary variable in one group compared to the prevalence in the other group, and the phi coefficient for measuring correlation between the treatment group and the binary variable. We found that a standardized difference of 10% (or 0.1) is equivalent to having a phi coefficient of 0.05 ...

1,532 citations

Journal ArticleDOI
TL;DR: During the Covid-19 outbreak in northern Italy, the daily rate of admissions for acute coronary syndrome at 15 hospitals was significantly lower than in previous outbreaks.
Abstract: Acute Coronary Syndrome during Covid-19 Outbreak During the Covid-19 outbreak in northern Italy, the daily rate of admissions for acute coronary syndrome at 15 hospitals was significantly lower tha...

825 citations

Journal ArticleDOI
TL;DR: The present article describes how most of these methods for estimating risk ratios from adjusted odds ratios when the outcome is common can be subsumed under a general formulation that also encompasses traditional standardization methods and methods for projecting the impact of partially successful interventions.
Abstract: Some recent articles have discussed biased methods for estimating risk ratios from adjusted odds ratios when the outcome is common, and the problem of setting confidence limits for risk ratios. These articles have overlooked the extensive literature on valid estimation of risks, risk ratios, and risk differences from logistic and other models, including methods that remain valid when the outcome is common, and methods for risk and rate estimation from case-control studies. The present article describes how most of these methods can be subsumed under a general formulation that also encompasses traditional standardization methods and methods for projecting the impact of partially successful interventions. Approximate variance formulas for the resulting estimates allow interval estimation; these intervals can be closely approximated by rapid simulation procedures that require only standard software functions.

671 citations

Related Papers (5)